Skip to content

PHARMACON

Active Private limited companyfounded 1996active for 30 yearsFilaturestraat 20, 9000 GhentKBO/BCE: BE 0457.066.176

Lifetime

20 annual accounts with figures on one time axis, 29 filings since 1996
peak of €111,098 in 2010
-€11,046▼ €964
lowest -€47,079 in 2023
-€33,237▼ €3,145
peak of €447,508 in 2015
€275,949▼ 10.7%
€113,488▼ 43.3%
Board1 name since 2021
1 director
Documentsfilings and deeds
28-07-20263 days before the deadline
2025micro format
Loss of €33,237Debts from €199,984 to €113,488Cash from €22,944 to €6,969

Key points

from the 2025 annual accounts

Losses

-€110,408 in three years
-47,0792023-30,0922024-33,2372025

Every financial year from 2023 to 2025 closed with a loss. 2023 was the heaviest.

Liquidity

0.32 was 1.15 in 2024

Short-term debts fell from €103,219 to €27,243.

Position in the sector

-€33,237

Lower net result than 95% of companies in head offices and management consultancy. Sector median €26,440 · 41,264 companies.

Turnover not published in the micro format

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 12,344 companies had the same profile as PHARMACON has now. Each dot stands for 31 companies, two years later.

90.1%
were still trading
8.7%
stopped another way
0.7%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a small loss

Another 0.5% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 12,344 companies, not a prediction for PHARMACON. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0457066176
Change of role: , from director to statutory director Director discharge: · General meeting of 12-05-2021 · Gazette deed
Registered office moved from Landegem to Ghent The registered office moved from Stationsstraat 32- 9850 LANDEGEM to Filaturastraat 20/301 te 9000 GENT · General meeting of 01-08-2018 · Gazette deed
First establishment At the time the registered office was still in Landegem, Stationsstraat 32.
All 44 events

Comparable companies

same main activity, similar in size and age
Company
PHARMACON Ghent €440,606 -€11,046 62.6% -
X - TENSION Ghent €401,608 -€34,214 63.9% -
Marc Van Hoecke & Co Sint-Martens-Latem €393,826 -€19,916 50.0% -
LV BAKE OFF SERVICE Aalst €358,036 -€407 94.1% -
LOG - X Aalst €378,453 -€15,017 97.6% -
FBO CONSULTING Gavere €345,072 -€5,703 83.6% -
SCHOENAERTS Temse €435,638 -€6,025 99.3% -

These companies have the same main activity as PHARMACON: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €345,000 and €436,000, founded between 1994 and 2001.

Official details

Source: KBO
Status
Active since 29-01-1996Normal situation
Activity
Business and other management consultancyNACE 70200
Establishment unit
2.075.091.2079000 Ghent, registered on 07-02-1996
Financial year end
31 December
Peppol
Reachable since 18-06-2025
Company details

Annual accounts 2025

€440,606▼ 21.7%
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on PHARMACON

PHARMACON files the micro format. That format states no turnover. The gross margin fell from €43,838 in 2006 to -€11,046 in 2025.

The balance sheet grew most in 2018 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PHARMACON

What is the company number of PHARMACON?
The company number of PHARMACON is 0457.066.176. The VAT number is the same number with BE in front: BE 0457.066.176.
Where is PHARMACON based?
The registered office is at Filaturestraat 20, 9000 Ghent.Company details
What does PHARMACON do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of PHARMACON?
PHARMACON is a private limited company (BV).
When was PHARMACON founded?
PHARMACON was founded on 29-01-1996.
Is PHARMACON still active?
Yes, PHARMACON is an active enterprise in the KBO register.
What is the turnover of PHARMACON?
The annual accounts for financial year 2025 state no turnover. The micro format does not require it.Financials
Is PHARMACON profitable?
In financial year 2025, PHARMACON made a loss of €33,237.
Where can I find the annual accounts of PHARMACON?
PHARMACON filed 29 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PHARMACON due?
PHARMACON must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.